Progress of bispecific antibody in cancer treatment / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 419-422, 2018.
Article
en Zh
| WPRIM
| ID: wpr-712841
Biblioteca responsable:
WPRO
ABSTRACT
Bispecific antibodies can target two different targets simultaneously with a wide application prospect and rapid development in tumor treatment. The main function is to recruit effector cells selectively in order to kill tumor cells or bind tumor-associated growth factor receptor to inhibit cell proliferation. This paper reviews the current situation of bispecific antibodies in design, mechanism of action and the research progress in the clinical cancer treatment.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Cancer Research and Clinic
Año:
2018
Tipo del documento:
Article